BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37551862)

  • 1. Re: Response to In regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors".
    Cheng H; Ding K; Yao S
    Integr Cancer Ther; 2023; 22():15347354231191715. PubMed ID: 37551862
    [No Abstract]   [Full Text] [Related]  

  • 2. In Regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors".
    Zarrella GV; Braun SE
    Integr Cancer Ther; 2023; 22():15347354231191706. PubMed ID: 37605802
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.
    Ding K; Zhang X; Zhao J; Zuo H; Bi Z; Cheng H
    Integr Cancer Ther; 2020; 19():1534735420938450. PubMed ID: 32683997
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
    Yao S; Zhu Q; Zhang Q; Cai Y; Liu S; Pang L; Jing Y; Yin X; Cheng H
    Cancer Med; 2023 Aug; 12(15):16231-16242. PubMed ID: 37409628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Managing Cancer and Living Meaningfully (CALM) Intervention Alleviates Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer by Modulating Pan-Immune-Inflammation Values.
    Yao S; Ding K; Liu S; Zhang Q; Li W; Tang L; Yu S; Pang L; Yin X; Cheng H
    Integr Cancer Ther; 2022; 21():15347354221140498. PubMed ID: 36419389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia.
    Syed Alwi SM; Narayanan V; Mohd Taib NA; Che Din N
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):534-545. PubMed ID: 34369307
    [No Abstract]   [Full Text] [Related]  

  • 7. The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.
    Kumar NB
    Curr Treat Options Oncol; 2021 Jun; 22(8):67. PubMed ID: 34110516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Perception among Post-Chemotherapy, Non-Chemotherapy Breast Cancer Survivors and Non-Cancer.
    Syarif H; Waluyo A; Afiyanti Y
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1775-1780. PubMed ID: 34181333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
    Syed Alwi SM; Mazlan M; Mohd Taib NA; Che Din N; Narayanan V
    PLoS One; 2022; 17(11):e0277056. PubMed ID: 36395277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Chemotherapy-Related Cognitive Impairment on Social Roles and Well-Being in Breast Cancer Survivors.
    Bailey LR; Craft M; Bert SSC; Carlson BW
    Oncol Nurs Forum; 2024 Feb; 51(2):153-162. PubMed ID: 38442283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective memory impairment in chemotherapy-exposed early breast cancer survivors: Preliminary evidence from a clinical test.
    Bedard M; Verma S; Collins B; Song X; Paquet L
    J Psychosoc Oncol; 2016; 34(4):291-304. PubMed ID: 27123566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-Based Cognitive Training for Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.
    Bail J; Meneses K
    Clin J Oncol Nurs; 2016 Oct; 20(5):504-9. PubMed ID: 27668370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial.
    Van der Gucht K; Melis M; Ahmadoun S; Gebruers A; Smeets A; Vandenbulcke M; Wildiers H; Neven P; Kuppens P; Raes F; Sunaert S; Deprez S
    Trials; 2020 Mar; 21(1):290. PubMed ID: 32293533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging From the Haze: A Multicenter, Controlled Pilot Study of a Multidimensional, Psychoeducation-Based Cognitive Rehabilitation Intervention for Breast Cancer Survivors Delivered With Telehealth Conferencing.
    Myers JS; Cook-Wiens G; Baynes R; Jo MY; Bailey C; Krigel S; Klemp J; Asher A
    Arch Phys Med Rehabil; 2020 Jun; 101(6):948-959. PubMed ID: 32179067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term changes of cognitive impairment among older breast cancer survivors.
    Luo J; Schousboe JT; Ensrud KE; Hendryx M
    J Cancer Surviv; 2023 Dec; 17(6):1760-1768. PubMed ID: 35624198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functioning in breast cancer survivors: a controlled comparison.
    Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
    Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of perceived cognitive impairment in breast cancer survivors.
    Von Ah D; Habermann B; Carpenter JS; Schneider BL
    Eur J Oncol Nurs; 2013 Apr; 17(2):236-41. PubMed ID: 22901546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness-based stress reduction and cognitive function among breast cancer survivors: A randomized controlled trial.
    Duval A; Davis CG; Khoo EL; Romanow H; Shergill Y; Rice D; Smith AM; Poulin PA; Collins B
    Cancer; 2022 Jul; 128(13):2520-2528. PubMed ID: 35385137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of health-related quality of life after completion of chemotherapy among Malaysian early-stage breast cancer survivors.
    Syed Alwi SM; Narayanan V; Mohd Taib NA; Che Din N
    Support Care Cancer; 2022 Mar; 30(3):2793-2801. PubMed ID: 34841453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.